Onex Corporation ONEXF Company Overview  Stock Message

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
Onex Corporation ONEXF Company Overview 

Stock Message Board http://investorshangout.com/search?q=ONEXF&am...mp;yt1=Go!

Onex Corporation ONEXF Current Price and Quotes
48.2865
Previous Close
47.64
Open
48.1634

Daily Range
48.2957 - 48.1634
52wk Range
51.633 - 38.52

Volume
13,400
Dividend
0.15

Average Vol (3m)
9,782
Yield
0.31

Onex Corporation ONEXF
Company Information
161 Bay St.
49th Floor
PO Box 700
Toronto, ONT M5J 2S1
Canada

Website: http://www.onex.com
Phone: 416-362-7711
Email: info@onex.com

Onex Corporation ONEXF
Onex Corporation ONEXF
Financial Reportings and Disclosures
Reporting Status International Reporting: Toronto Stock Exchange
Fiscal Year End Not Available
OTC Marketplace Grey Market
Profile Data
SIC - Industry Classification
Incorporated In: Canada
Year of Inc. Not Available
Employees Not Available
Company Officers/Contacts
Gerald W. Schwartz CEO
Donald Lewtas CFO
Company Directors
Gerald W. Schwartz Chairman
Service Providers
Auditor/Accountant
Not Available
Legal Counsel
Not Available
Investor Relations Firm
Not Available

Onex Corporation ONEXF
ONEXF Security Details
Share Structure
Market Value1 $5,578,549,002 a/o Sep 04, 2013
Shares Outstanding 115,530,200 a/o Nov 30, 2011
Float Not Available
Authorized Shares Not Available
Par Value  No Par Value
Shareholders
Shareholders of Record Not Available
Non US Stock Exchange Listing
OCX - Toronto Stock Exchange - Qualified
Short Selling Data
Short Interest 16,955 (53.95%)
Aug 15, 2013
Significant Failures to Deliver  No
Transfer Agent(s)
Canadian Stock Transfer Company, Inc

Onex Corporation ONEXF Recent News


Aug 27, 2013 The Pritzker Organization to acquire TMS in $1bn deal
Aug 27, 2013 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims That the Merger May Not Be in the Best Interest of Investors of TMS International Corp. - TMS
Aug 26, 2013 Onex to Sell Remaining Stake in TMS International Corp.
Aug 13, 2013 Onex Reports Second-Quarter 2013 Consolidated Results
Aug 8, 2013 Onex Second Quarter 2013
Jul 22, 2013 Onex to Announce Second-Quarter Results on August 8, 2013
Jun 17, 2013 Onex Completes Acquisition of Nielsen Expositions
Jun 12, 2013 Canada : Carestream Health to Distribute $725 million
Jun 10, 2013 Carestream Health to Distribute $725 Million


Onex Corporation ONEXF Financials
ONEXF

ONEXF Onex Corporation Research DD Guide

ONEXF Onex Corporation Stock Message Board http://investorshangout.com/search?q=ONEXF&am...mp;yt0=Go!
ONEXF Onex Corporation Stock Quote http://www.otcmarkets.com/stock/ONEXF/quote
ONEXF Onex Corporation Stock Chart http://www.otcmarkets.com/stock/ONEXF/chart
ONEXF Onex Corporation Company Info http://www.otcmarkets.com/stock/ONEXF/company-info
ONEXF Onex Corporation Recent News http://www.otcmarkets.com/stock/ONEXF/news
ONEXF Onex Corporation Financials http://www.otcmarkets.com/stock/ONEXF/financials
ONEXF Onex Corporation Filings and Disclosure http://www.otcmarkets.com/stock/ONEXF/filings
ONEXF Onex Corporation Short Sales http://www.otcmarkets.com/stock/ONEXF/short-sales
ONEXF Onex Corporation Insider Disclosure http://www.otcmarkets.com/stock/ONEXF/insider-transactions
ONEXF Onex Corporation Research Reports http://www.otcmarkets.com/stock/ONEXF/research
ONEXF Onex Corporation Summary http://finance.yahoo.com/q?s=ONEXF
ONEXF Onex Corporation Historical Prices http://finance.yahoo.com/q/hp?s=ONEXF+Historical+Prices
ONEXF Onex Corporation Interactive Chart http://finance.yahoo.com/echarts?s=ONEXF
ONEXF Onex Corporation Basic Chart http://finance.yahoo.com/q/bc?s=ONEXF+Basic+Chart
ONEXF Onex Corporation Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=ONEXF+Basic+Tech.+Analysis
ONEXF Onex Corporation Headlines http://finance.yahoo.com/q/h?s=ONEXF+Headlines
ONEXF Onex Corporation Press Releases http://finance.yahoo.com/q/p?s=ONEXF+Press+Releases
ONEXF Onex Corporation Company Profile http://finance.yahoo.com/q/pr?s=ONEXF+Profile
ONEXF Onex Corporation Key Statistics http://finance.yahoo.com/q/ks?s=ONEXF+Key+Statistics
ONEXF Onex Corporation Industry http://finance.yahoo.com/q/in?s=ONEXF+Industry
ONEXF Onex Corporation Major Holders http://finance.yahoo.com/q/mh?s=ONEXF+Major+Holders
ONEXF Onex Corporation Insider Transactions http://finance.yahoo.com/q/it?s=ONEXF+Insider+Transactions
ONEXF Onex Corporation Insider Roster http://finance.yahoo.com/q/ir?s=ONEXF+Insider+Roster
ONEXF Onex Corporation Income Statement http://finance.yahoo.com/q/is?s=ONEXF
ONEXF Onex Corporation Balance Sheet http://finance.yahoo.com/q/bs?s=ONEXF
ONEXF Onex Corporation Cash Flow http://finance.yahoo.com/q/cf?s=ONEXF+Cash+Flow&annual
ONEXF Onex Corporation Nasdaq http://www.nasdaq.com/symbol/ONEXF
ONEXF Onex Corporation Market Watch http://www.marketwatch.com/investing/stock/ONEXF
ONEXF Onex Corporation Bloomberg http://www.bloomberg.com/quote/ONEXF:US
ONEXF Onex Corporation Morningstar http://quotes.morningstar.com/stock/s?t=ONEXF
ONEXF Onex Corporation Bussinessweek http://investing.businessweek.com/research/st...cker=ONEXF
ONEXF Onex Corporation Barchart http://www.barchart.com/quotes/stocks/ONEXF
ONEXF Onex Corporation OTC Short Report http://otcshortreport.com/index.php?index=ONEXF
ONEXF Onex Corporation Investopedia http://www.investopedia.com/markets/stocks/ONEXF/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 15

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 11

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 20

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 17

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 22

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 19

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 20

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 23

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 18

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading

Top 5 Most Recently Viewed Articles

Insights into Stella-Jones Conference Call for Q3 Results

Updated Category News Views 70

Upcoming Conference Call for Stella-Jones Inc. Stella-Jones Inc. (TSX: SJ), a prominent player in the manufacturing of pressure-treated wood products, is set to hold a significant conference call to discuss its third quarter results. Details of the Conference Call The conference call is open to investors, analysts, and all interested parties. It will take place on...

Continue Reading
Total Voting Rights Announcement for Northern Venture Trust

Updated Category News Views 75

Update on Total Voting Rights Northern Venture Trust PLC has released a key update concerning its total voting rights. In line with the Financial Conduct Authority’s Disclosure Guidance and Transparency Rules, the Company is informing the market about its present capital structure. Overview of Ordinary Shares As per the latest information, Northern Venture Trust PLC's...

Continue Reading
Northrop Grumman Faces Investor Scrutiny Amid Financial Decline

Updated Category News Views 431

Investor Concerns Around Northrop Grumman Investors holding shares in Northrop Grumman Corporation (NYSE: NOC) are facing critical developments as they are encouraged to evaluate their positions in light of recent financial disclosures and ongoing investigations by legal entities. This alert revolves around Northrop Grumman's recent performance and future implications...

Continue Reading
Nature's Sunshine Welcomes Katie May to Board Leadership

Updated Category News Views 420

Nature's Sunshine Embraces New Leadership with Katie A. May Nature's Sunshine Products, Inc. is thrilled to announce that Katie A. May has joined its board of directors, marking a significant step in enhancing leadership and direction within the company. With a rich background in ecommerce and logistics, Katie's new role reflects the company's commitment to further...

Continue Reading
NewAmsterdam Pharma Announces Participation in Key Investor Conferences

Updated Category News Views 79

NewAmsterdam Pharma to Attend Investor Conferences NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS) is a leading biopharmaceutical firm committed to creating innovative oral medications designed to reduce low-density lipoprotein (LDL) cholesterol levels for individuals at risk of cardiovascular disease (CVD). The company is preparing for a series of upcoming investor...

Continue Reading